Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Nanda R. “Targeting” triple-negative breast cancer: the lessons learned from BRCA1-associated breast cancers. Semin Oncol 2011; 38:254 - 62; http://dx.doi.org/10.1053/j.seminoncol.2011.01.007; PMID: 21421115
   PubMed Web of Science ®Google Scholar
• Chiang AC, Massagué J. Molecular basis of metastasis. N Engl J Med 2008; 359:2814 - 23; http://dx.doi.org/10.1056/NEJMra0805239; PMID: 19109576
   PubMed Web of Science ®Google Scholar
• Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 2005; 23:7350 - 60; http://dx.doi.org/10.1200/JCO.2005.03.3845; PMID: 16145060
   PubMed Web of Science ®Google Scholar
• Kruger JS, Reddy KB. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 2003; 1:801 - 9; PMID: 14517342
   PubMed Web of Science ®Google Scholar
• Morris C. The role of EGFR-directed therapy in the treatment of breast cancer. Breast Cancer Res Treat 2002; 75 Suppl 1:S51-5; discussion S7-9.
   Google Scholar
• Mesaki K, Tanabe K, Obayashi M, Oe N, Takei K. Fission of tubular endosomes triggers endosomal acidification and movement. PLoS One 2011; 6:e19764; http://dx.doi.org/10.1371/journal.pone.0019764; PMID: 21572956
   PubMedGoogle Scholar
• Huotari J, Helenius A. Endosome maturation. EMBO J 2011; 30:3481 - 500; http://dx.doi.org/10.1038/emboj.2011.286; PMID: 21878991
   PubMed Web of Science ®Google Scholar
• Ganley IG, Wong PM, Gammoh N, Jiang X. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 2011; 42:731 - 43; http://dx.doi.org/10.1016/j.molcel.2011.04.024; PMID: 21700220
   PubMed Web of Science ®Google Scholar
• Wang T, Ming Z, Xiaochun W, Hong W. Rab7: role of its protein interaction cascades in endo-lysosomal traffic. Cell Signal 2011; 23:516 - 21; http://dx.doi.org/10.1016/j.cellsig.2010.09.012; PMID: 20851765
   PubMed Web of Science ®Google Scholar
• Jordens I, Fernandez-Borja M, Marsman M, Dusseljee S, Janssen L, Calafat J, et al. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol 2001; 11:1680 - 5; http://dx.doi.org/10.1016/S0960-9822(01)00531-0; PMID: 11696325
   PubMed Web of Science ®Google Scholar
• Fehrenbacher N, Jäättelä M. Lysosomes as targets for cancer therapy. Cancer Res 2005; 65:2993 - 5; PMID: 15833821
   PubMed Web of Science ®Google Scholar
• Sun-Wada GH, Wada Y, Futai M. Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase. Cell Struct Funct 2003; 28:455 - 63; http://dx.doi.org/10.1247/csf.28.455; PMID: 14745137
   PubMed Web of Science ®Google Scholar
• Roepstorff K, Grøvdal L, Grandal M, Lerdrup M, van Deurs B. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochem Cell Biol 2008; 129:563 - 78; http://dx.doi.org/10.1007/s00418-008-0401-3; PMID: 18288481
   PubMed Web of Science ®Google Scholar
• Cuddeback SM, Yamaguchi H, Komatsu K, Miyashita T, Yamada M, Wu C, et al. Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 2001; 276:20559 - 65; http://dx.doi.org/10.1074/jbc.M101527200; PMID: 11259440
   PubMed Web of Science ®Google Scholar
• Pierrat B, Simonen M, Cueto M, Mestan J, Ferrigno P, Heim J. SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics 2001; 71:222 - 34; http://dx.doi.org/10.1006/geno.2000.6378; PMID: 11161816
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Meyerkord CL, Wang HG. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy. Cell Death Differ 2009; 16:947 - 55; http://dx.doi.org/10.1038/cdd.2009.19; PMID: 19265852
   PubMed Web of Science ®Google Scholar
• Lee JW, Jeong EG, Soung YH, Nam SW, Lee JY, Yoo NJ, et al. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006; 38:312 - 5; http://dx.doi.org/10.1080/00313020600820880; PMID: 16916719
   PubMed Web of Science ®Google Scholar
• Coppola D, Khalil F, Eschrich SA, Boulware D, Yeatman T, Wang HG. Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma. Cancer 2008; 113:2665 - 70; http://dx.doi.org/10.1002/cncr.23892; PMID: 18833585
   PubMed Web of Science ®Google Scholar
• Coppola D, Oliveri C, Sayegh Z, Boulware D, Takahashi Y, Pow-Sang J, et al. Bax-interacting factor-1 expression in prostate cancer. Clin Genitourin Cancer 2008; 6:117 - 21; http://dx.doi.org/10.3816/CGC.2008.n.018; PMID: 18824435
   PubMed Web of Science ®Google Scholar
• Coppola D, Helm J, Ghayouri M, Malafa MP, Wang HG. Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. Pancreas 2011; 40:433 - 7; http://dx.doi.org/10.1097/MPA.0b013e318205eb03; PMID: 21283040
   PubMed Web of Science ®Google Scholar
• Kim SY, Oh YL, Kim KM, Jeong EG, Kim MS, Yoo NJ, et al. Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers. Pathology 2008; 40:553 - 7; http://dx.doi.org/10.1080/00313020802320440; PMID: 18752120
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007; 9:1142 - 51; http://dx.doi.org/10.1038/ncb1634; PMID: 17891140
   PubMed Web of Science ®Google Scholar
• Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, et al. Novel breast cancer metastasis-associated proteins. J Proteome Res 2009; 8:583 - 94; http://dx.doi.org/10.1021/pr8007368; PMID: 19086899
   PubMed Web of Science ®Google Scholar
• Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1987; 1:216 - 23; http://dx.doi.org/10.1210/mend-1-3-216; PMID: 3502607
   PubMed Web of Science ®Google Scholar
• Rakha EA, Chan S. Metastatic triple-negative breast cancer. Clin Oncol (R Coll Radiol) 2011; 23:587 - 600; http://dx.doi.org/10.1016/j.clon.2011.03.013; PMID: 21524569
   PubMed Web of Science ®Google Scholar
• Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436:518 - 24; http://dx.doi.org/10.1038/nature03799; PMID: 16049480
   PubMed Web of Science ®Google Scholar
• Thoresen SB, Pedersen NM, Liestøl K, Stenmark H. A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic. Exp Cell Res 2010; 316:3368 - 78; http://dx.doi.org/10.1016/j.yexcr.2010.07.008; PMID: 20643123
   PubMed Web of Science ®Google Scholar
• Zhang C, Li A, Zhang X, Xiao H. A novel TIP30 protein complex regulates EGF receptor signaling and endocytic degradation. J Biol Chem 2011; 286:9373 - 81; http://dx.doi.org/10.1074/jbc.M110.207720; PMID: 21252234
   PubMed Web of Science ®Google Scholar
• Wan J, Cheung AY, Fu WY, Wu C, Zhang M, Mobley WC, et al. Endophilin B1 as a novel regulator of nerve growth factor/ TrkA trafficking and neurite outgrowth. J Neurosci 2008; 28:9002 - 12; http://dx.doi.org/10.1523/JNEUROSCI.0767-08.2008; PMID: 18768694
   PubMed Web of Science ®Google Scholar
• Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: a key to lysosome biogenesis. Mol Biol Cell 2000; 11:467 - 80; PMID: 10679007
   PubMed Web of Science ®Google Scholar
• Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta 2000; 291:113 - 35; http://dx.doi.org/10.1016/S0009-8981(99)00224-7; PMID: 10675719
   PubMed Web of Science ®Google Scholar
• Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005; 15:138 - 45; http://dx.doi.org/10.1016/j.tcb.2005.01.003; PMID: 15752977
   PubMed Web of Science ®Google Scholar
• Ringstad N, Nemoto Y, De Camilli P. The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Proc Natl Acad Sci U S A 1997; 94:8569 - 74; http://dx.doi.org/10.1073/pnas.94.16.8569; PMID: 9238017
   PubMed Web of Science ®Google Scholar
• Gad H, Ringstad N, Löw P, Kjaerulff O, Gustafsson J, Wenk M, et al. Fission and uncoating of synaptic clathrin-coated vesicles are perturbed by disruption of interactions with the SH3 domain of endophilin. Neuron 2000; 27:301 - 12; http://dx.doi.org/10.1016/S0896-6273(00)00038-6; PMID: 10985350
   PubMed Web of Science ®Google Scholar
• Rostovtseva TK, Boukari H, Antignani A, Shiu B, Banerjee S, Neutzner A, et al. Bax activates endophilin B1 oligomerization and lipid membrane vesiculation. J Biol Chem 2009; 284:34390 - 9; http://dx.doi.org/10.1074/jbc.M109.021873; PMID: 19805544
   PubMed Web of Science ®Google Scholar
• Liang C, Lee JS, Inn KS, Gack MU, Li Q, Roberts EA, et al. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol 2008; 10:776 - 87; http://dx.doi.org/10.1038/ncb1740; PMID: 18552835
   PubMed Web of Science ®Google Scholar
• Rink J, Ghigo E, Kalaidzidis Y, Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell 2005; 122:735 - 49; http://dx.doi.org/10.1016/j.cell.2005.06.043; PMID: 16143105
   PubMed Web of Science ®Google Scholar
• Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G. Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett 1998; 425:145 - 50; http://dx.doi.org/10.1016/S0014-5793(98)00224-5; PMID: 9541025
   PubMed Web of Science ®Google Scholar
• Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84:359 - 69; http://dx.doi.org/10.1016/S0092-8674(00)81280-5; PMID: 8608589
   PubMed Web of Science ®Google Scholar
• Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010; 8:23; http://dx.doi.org/10.1186/1478-811X-8-23; PMID: 20822528
   PubMed Web of Science ®Google Scholar
• Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997; 137:481 - 92; http://dx.doi.org/10.1083/jcb.137.2.481; PMID: 9128257
   PubMed Web of Science ®Google Scholar
• Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003; 22:395 - 403; http://dx.doi.org/10.1023/A:1023781114568; PMID: 12884914
   PubMed Web of Science ®Google Scholar